Skip to main content
Independent and nonpartisan. SaveYourState is a civic information resource. It is not a government website and is not affiliated with any government agency, party, or campaign.

Hawaii · 2026 Regular Session · Bill

SB 1633: RELATING TO HEMP.

In committee Official data

  1. Introduced
  2. In committee
  3. Passed one chamber
  4. Passed both chambers
  5. Enacted

Last official action: ·Record last updated:

Plain-language summary

SB 1633 is a bill introduced in the Hawaii Senate on January 23, 2025. According to its official title, it concerns: RELATING TO HEMP. Primary sponsor: Mike Gabbard (Democratic), Tim Richards (Democratic). Most recent recorded action (December 8, 2025): Carried over to 2026 Regular Session.

Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written

Official summary

Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.

Establishes a Green Building Tax Credit for costs related to the construction of a primary structure made with at least thirty per cent Hawaii-grown hemp material. Allows any hemp processor with a permit from the Department of Health to sell an edible or beverage cannabinoid product that contains a tetrahydrocannabinol concentration of not more than 2.5 milligrams per serving and not more than twenty-five servings per package. Prohibits the sale of an edible or beverage cannabinoid product to any person less than twenty-one years of age. Establishes child-resistant packaging requirements for edible cannabinoid products. Clarifies the tetrahydrocannabinol concentration limit for a non-edible legacy cannabinoid product or manufactured hemp product shall be subject only to federal restrictions. Amends the definition of "hemp biomass" to include stalks and foliage material. Requires the Department of Health to establish a dedicated hemp program to regulate hemp that is separate from the regulatory process for cannabinoid products with a high concentration of tetrahydrocannabinol. Effective 7/1/2050. (SD1)

Sponsors

Sponsors by party (alphabetical): Democratic 2

NameRolePartyChamberDistrict
Mike GabbardPrimary sponsorDemocraticSenate21
Tim RichardsPrimary sponsorDemocraticSenate4

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

  1. Carried over to 2026 Regular Session.
  2. Reported from AEN/HHS (Stand. Com. Rep. No. 647) with recommendation of passage on Second Reading, as amended (SD 1) and referral to CPN/WAM.
  3. Report adopted; Passed Second Reading, as amended (SD 1) and referred to CPN/WAM.
  4. The committee(s) on AEN recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in AEN were as follows: 5 Aye(s): Senator(s) Gabbard, Richards, DeCoite, Rhoads, Awa; Aye(s) with reservations: none ; 0 No(es): none; and 0 Excused: none.
  5. The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in HHS were as follows: 4 Aye(s): Senator(s) San Buenaventura, Aquino, Hashimoto, Keohokalole; Aye(s) with reservations: none ; 0 No(es): none; and 1 Excused: Senator(s) Fevella.
  6. The committee(s) on AEN deferred the measure until 02-12-25 1:00PM; CR 224 & Videoconference.
  7. The committee(s) on HHS deferred the measure until 02-12-25 1:30PM; CR 225 & Videoconference.
  8. The committee(s) on AEN deferred the measure until 02-10-25 1:01PM; CR 224 & Videoconference.
  9. The committee(s) on HHS deferred the measure until 02-10-25 1:01PM; CR 225 & Videoconference.
  10. The committee(s) on AEN/HHS has scheduled a public hearing on 02-07-25 2:00PM; Conference Room 225 & Videoconference.
  11. Passed First Reading.
  12. Referred to AEN/HHS, CPN/WAM.

Showing 12 most recent of 13 actions. Full history

Sources

  1. Open States / Plural (data from the official legislature website)
  2. Official legislature source